Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,190.00    17.00 (1.45%)
Bid:
1,186.00
Ask:
1,191.00
Spread: 5.00 (0.422%)
Market Cap: £823.48m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Trading Update

21 Jul 2014 07:00

RNS Number : 7799M
CVS Group plc
21 July 2014
 

 

21 July 2014

 

CVS Group plc ("CVS" or the "Group")

 

Trading Update

 

CVS, the UK's leading provider of integrated veterinary services, is pleased to provide the following trading update in respect of the financial year ended 30 June 2014. Comparative data relates to the year ended 30 June 2013 unless otherwise stated. The Group will announce its full year results on Friday 19 September 2014 and these are expected to be in line with market expectations.

 

Group revenue for the year showed total like-for-like growth of 6.9%. This figure benefitted from good weather throughout the winter months and is stated after adjusting for one extra day's trading in the year to 30 June 2013. Like-for-like sales performance was strong in all the main businesses, particularly in Animed Direct. CVS continues to see opportunities for organic growth across all of its activities and continues to invest in the estate to capitalise on this potential.

 

Strong organic growth has been achieved in the core veterinary practices especially in the second half of the year. Membership of our Healthy Pet Club loyalty schemes grew by 50,100 (44.8%), from 111,900 pets at the start of the year to 162,000 at the year end. In the previous year membership grew by 46,400. Based on the current run rate these schemes are now contributing over 11% of the total revenue from practices (2013: 9%).

 

The scale and increasing density of our practice network has enabled the Group to open four emergency out-of-hours centres during the year, bringing work previously performed by third parties into the Group. Further opportunities for similar changes will be sought during 2015.

 

Good progress has been made in developing our referrals business with organic growth continuing in the centres that we already operate. In July 2014 we purchased the freehold of Lumbry Park, Alton, Hampshire for £800,000 and we are now developing plans for fitting it out as a first-class multi-disciplinary referral centre. This centre is expected to open in the summer of 2015.

 

It is pleasing to report that significant growth has continued in Animed Direct, our online dispensary. It is currently generating some £10.4 million of annualised revenue, based on revenue for June 2014, compared with £6.7 million based on June 2013. The varying regulatory requirements in Europe have led to a slight delay in launching our planned local language European websites and the first is now expected to be launched within the next few months.

 

Acquisition activity has continued to play an important part in the Group's strategy. In addition to the seven practices acquired in the first half of the year, three practices - 3 Mile (Glasgow), Ashfield (3 sites around Halifax) and Castle (3 sites in Barnard Castle, County Durham) - and a pet crematorium (Silvermere Haven in Cobham) were acquired during the second half. These acquisitions extend the Practice Division's operations and the practices are an excellent geographic fit with the Group's existing surgeries. The acquisition of Silvermere Haven is an important step in the geographic development of our Crematoria Division and will allow almost all of our practices to be serviced internally.

 

All of the acquisitions have been successfully integrated into the Group. The aggregate turnover of acquisitions in their last financial year prior to acquisition totalled £13.3 million. The actual post acquisition turnover of businesses acquired during the year ended 30 June 2014 was £6.6m.

 

The Group now operates a total of 262 veterinary practices across the UK, an on-line dispensary, 5 diagnostic laboratories and 3 pet crematoria.

 

 

The Board is encouraged by the recent improvement in like-for-like sales performance, the continuing potential for further acquisitions and the general progress in all divisions of the Group.

 

 

For further enquiries please contact:

 

CVS Group plc: 01379 644 288

Simon Innes - Chief Executive

Nick Perrin - Finance Director

 

N+1 Singer (Nominated Adviser & Broker) 020 7496 3000

Aubrey Powell / Alex Wright

Nick Owen

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGMNDRFGDZM
Date   Source Headline
30th May 202512:54 pmRNSTotal Voting Rights
19th May 20257:00 amRNSCompletion of Crematorium Operations Disposal
8th May 20255:25 pmRNSStandard form for notification of major holdings
30th Apr 20257:00 amRNSTotal Voting Rights
24th Apr 20257:00 amRNSDisposal of Crematorium Operations
31st Mar 20257:00 amRNSTotal Voting Rights
28th Mar 20253:03 pmRNSPDMR Dealing
13th Mar 20254:17 pmRNSStandard form for notification of major holdings
28th Feb 20259:57 amRNSTotal Voting Rights
27th Feb 20257:00 amRNSInterim Results
6th Feb 20259:24 amRNSStandard form for notification of major holdings
31st Jan 20257:00 amRNSTotal Voting Rights
30th Jan 20257:00 amRNSHalf Year Trading Update
13th Jan 20257:00 amRNSBlock listing Interim Review
7th Jan 20257:00 amRNSDirector/PDMR Shareholding
31st Dec 202410:52 amRNSTotal Voting Rights
29th Nov 20247:00 amRNSTotal Voting Rights
26th Nov 20241:59 pmRNSGrant of Options & PDMR Dealing
21st Nov 20244:05 pmRNSStandard form for notification of major holdings
20th Nov 202412:51 pmRNSResult of AGM
20th Nov 20247:00 amRNSAGM Statement and Trading Update
4th Nov 20249:18 amRNSStandard form for notification of major holdings
31st Oct 202411:35 amRNSExercise of Options and Total Voting Rights
30th Oct 20244:11 pmRNSStandard form for notification of major holdings
21st Oct 202410:42 amRNSPosting of Annual Report and Notice of AGM
16th Oct 202412:14 pmRNSStandard form for notification of major holdings
14th Oct 20242:34 pmRNSnotification of major holdings
11th Oct 20245:28 pmRNSHolding(s) in Company
4th Oct 20245:11 pmRNSLong Term Incentive Plan Awards and PDMR Dealing
3rd Oct 20247:00 amRNSNotification of major holdings
1st Oct 20247:00 amRNSTotal Voting Rights
26th Sep 20247:00 amRNSFinal results for the year ended 30 June 2024
2nd Sep 20242:45 pmRNSTotal Voting Rights
31st Jul 20247:00 amRNSTotal Voting Rights
30th Jul 20249:42 amRNSHolding(s) in Company
25th Jul 20247:00 amRNSTrading Statement
12th Jul 20247:00 amRNSBlock Listing Interim Review
11th Jul 20241:55 pmRNSPDMR Dealing
28th Jun 20247:00 amRNSExercise of Options and Total Voting Rights
27th Jun 20242:53 pmRNSDirector/PDMR Shareholding
24th Jun 20244:48 pmRNSPDMR Dealing
18th Jun 20241:35 pmRNSDirectorate Change
31st May 20247:00 amRNSTotal Voting Rights
23rd May 20247:12 amRNSResponse to CMA announcement
21st May 20247:00 amRNSDisposal of non-core operations
1st May 20247:00 amRNSAppointment of Non-executive Chair
30th Apr 20247:00 amRNSTotal Voting Rights
11th Apr 20245:48 pmRNSStandard form for notification of major holdings
8th Apr 20247:00 amRNSNotice of Cyber Incident
28th Mar 20244:07 pmRNSExercise of Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.